Embryonic Stem Cell Research Advocates Threaten Pro-Life Lawmakers in 2006

Bioethics   |   Steven Ertelt   |   May 1, 2006   |   9:00AM   |   WASHINGTON, DC

Embryonic Stem Cell Research Advocates Threaten Pro-Life Lawmakers in 2006

Email this article
Printer friendly page

by Steven Ertelt
LifeNews.com Editor
May 1, 2006

Palo Alto, CA (LifeNews.com) — Embryonic stem cell research advocates are threatening pro-life lawmakers in advance of the November elections, saying they will be "held accountable" for opposing using taxpayer funds to pay for the research that involves the destruction of human life.

The Genetics Policy Institute is planning a June summit stem cell research policy at Stanford University. The meeting is co-sponsored by Coalition for the Advancement of Medical Research, the biotech lobbying group, and is an attempt to get embryonic stem cell research advocates together and discuss ways to use the issue in the upcoming elections.

Bernard Siegel, executive director of the Genetics Policy Institute, describes the gathering in the kind of fatalistic terms pro-life lawmakers can expect to see used in television commercials against them this fall.

"Where delay is measured in human suffering and death, thoughtful people from around the world are demanding that stem cell research for cures proceed as rapidly as possible," he said.

"Stem cell research is a key wedge issue and certain elected officials will likely be held accountable for denying patients’ hope for cures," Siegel threatened.

Siegel said the summit will be a place to orchestrate strategy against pro-life candidates by painting them as unconcerned with helping patients because they don’t back the ineffective research — which has yet to help a single person.

"The Summit will empower the broad and rapidly expanding ‘Pro-Cures Coalition’ movement, which will play an absolutely pivotal role in the electoral process in 2006 and 2008," Siegel said.

The center for Biomedical Ethics at Stanford University with co-host the summit and will feature a presentation from Klein, chair of the California Institute for Regenerative Medicine which will spend billions on embryonic stem cell research and human cloning in the Golden State.